Glass House Brands (GLAS) Receivables - Net (2020 - 2026)
Glass House Brands' (GLAS) quarterly Receivables - Net came in at $6.4 million in Q1 2026, down 4.04% year-on-year from $6.7 million in Q1 2025, and up 45.82% on a QoQ basis from $4.4 million in Q4 2025.
Glass House Brands (GLAS) Receivables - Net (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Receivables - Net data on file, last reported at $6.4 million in Q1 2026.
- On a quarterly basis, Receivables - Net fell 4.04% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 4.04% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 7.47% from the prior year.
- Receivables - Net for Q1 2026 stood at $6.4 million, up from $4.4 million in the prior quarter.
- Over the last five years, Receivables - Net for GLAS reached as high as $9.8 million in Q2 2025 and fell as low as $2.5 million in Q1 2022.
- Historically, Receivables - Net has averaged $5.4 million across 5 years, with a median of $5.2 million in 2024.
- Across the five-year window, Receivables - Net surged 154.39% in 2022 and sank 38.13% in 2023, its largest moves.
- Year by year, Receivables - Net stood at $5.2 million in 2022, then dropped by 10.38% to $4.7 million in 2023, then grew by 11.18% to $5.2 million in 2024, then fell by 15.4% to $4.4 million in 2025, then surged by 45.82% to $6.4 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $6.4 million in Q1 2026, $4.4 million in Q4 2025, and $6.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.44 Mn |
| Mar 31, 2026 | 6.44 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 9.84 Mn |
| Jun 30, 2025 | 9.84 Mn |
| Mar 31, 2025 | 6.71 Mn |
| Mar 31, 2025 | 6.71 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 7.72 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Dec 31, 2023 | 4.70 Mn |